CD122 signaling in CD8+ memory T cells drives costimulation-independent rejection

David V. Mathews, Ying Dong, Laura B. Higginbotham, Steven C. Kim, Cynthia P. Breeden, Elizabeth A. Stobert, Joseph Jenkins, J. Yun Tso, Christian P. Larsen, Andrew B. Adams

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Interrupting T cell costimulatory signals as a strategy to control undesired immune responses, such as occur in autoimmunity or transplantation, has the potential to alleviate many of the unwanted side effects associated with current immunosuppressive therapies. Belatacept, a high-affinity version of CTLA4-Ig that blocks ligand ligation to CD28, has been approved for use in kidney transplant recipients. Despite the long-term benefits associated with its use, such as improved renal function and lower cardiovascular risk, a subset of patients treated with belatacept experience elevated rates of acute T cell-mediated rejection, tempering enthusiasm for its use. Here we demonstrate that costimulation-independent T cell alloreactivity relies on signaling through CD122, the shared IL-2 and IL-15 receptor β-chain. Combined costimulatory and CD122 blockade improved survival of transplanted tissue in mice and nonhuman primates by controlling proliferation and effector function of CD8+ T cells. The high-affinity IL-2 receptor was dispensable for memory CD8+ T cell responses, whereas signaling through CD122 as a component of the high-affinity IL-15 receptor was critical for costimulation-independent memory CD8+ T cell recall, distinguishing specific roles for IL-2 and IL-15 in T cell activation. These studies outline a novel approach for clinical optimization of costimulatory blockade strategies in transplantation by targeting CD122.

Original languageEnglish (US)
Pages (from-to)4557-4572
Number of pages16
JournalJournal of Clinical Investigation
Issue number10
StatePublished - Oct 1 2018
Externally publishedYes

Bibliographical note

Funding Information:
DVM was supported by the NIH Ruth L. Kirschstein National Research Service Award Individual Predoctoral MD/PhD Fellowship (F30 DK109665). The primate experiments were also supported by the National Institute for Allergy and Infectious Diseases Nonhuman Primate Transplantation Tolerance Cooperative Study Group grant AI051731 from NIH. Primate experiments were also supported by the Yerkes National Primate Research Center base grant RR00165.


Dive into the research topics of 'CD122 signaling in CD8<sup>+</sup> memory T cells drives costimulation-independent rejection'. Together they form a unique fingerprint.

Cite this